Comparison between the analgesic effects of morphine and tramadol delivered epidurally in cats receiving a standardized noxious stimulation

Background Gelsemium dilutions are prescribed for their anxiolytic and its analgesic effects. Investigations using alkaloids isolated from Gelsemium support the hypothesis of Gelsemium-induced analgesia. Aims We evaluated the antinociceptive effect of Gelsemium dilutions 3, 5 and 9C in neuropathic models. Methodology To investigate the potential effect of Gelsemium dilutions 3, 5 and 9C to prevent or to correct sciatic nerve chronic constriction (CCI) injury, we used the von-Frey hair behavioral test. CCI-induced neuropathic pain in rats represents characteristic painful behaviors like hyperalgesia and allodynia, thus validating its suitability for the evaluation of anti-neuropathic drugs. To test the corrective effect, Gelsemium 3, 5 or 9 C or placebo were administered from Day 14 after sciatic nerve ligation, i.e., when neuropathic symptoms were observed. In the preventive strategy, Gelsemium dilutions and placebo began immediately after the sciatic nerve ligation (D0). Results and discussion We observed that in placebo groups, the mechanical-sensitivity thresholds remained unchanged all treatment days whereas Gelsemium dilutions 3C and 5C exerted a strong or moderate antinociceptive effect, respectively. In CCI-rats, the contralateral paw of placebo-treated animals did not respond to 4g non-noxious stimulation but the ipsilateral responses increased progressively (0%-D0, 52%-D14, 72%-D21 and 88%-D28), confirming the occurrence of allodynia. Gelsemium dilution 3C corrective and preventive treatments efficiently reduced the allodynic responses (72-to-38%-D21 and 88-to-22%-D28). Gelsemium 5C also exhibited significant anti-allodynic action while Gelsemium 9C was ineffective. Similarly, one week treatment with Gelsemium 3 or 5C efficiently reduced 15g or 26g-evoked hyperalgesia and the beneficial action improved after 2 weeks. Chronic therapies with current analgesics induce several side-effects. Conclusion The present work, suggest that Gelsemium dilutions devoid of toxicity and used as anxiolytic in humans induced analgesia, opens interesting/alternative perspectives for long-term management of pain without undesirable effects.

Download Full-text

Biocompatibility and Pharmacological Effects of Innovative Systems for Prolonged Drug Release Containing Dexketoprofen in Rats

Polymers ◽

10.3390/polym13071010 ◽

2021 ◽

Vol 13 (7) ◽

pp. 1010

Author(s):

Liliana Mititelu-Tartau ◽

Maria Bogdan ◽

Daniela Angelica Pricop ◽

Beatrice Rozalina Buca ◽

Loredana Hilitanu ◽

...

Keyword(s):

Body Weight ◽

Time Response ◽

Noxious Stimulation ◽

Latency Time ◽

Hot Plate ◽

Hot Plate Test ◽

Plate Test ◽

Analgesic Effects ◽

Group I

The present study reports on the in vivo biocompatibility investigation and evaluation of the effects of liposomes containing dexketoprofen in somatic sensitivity in rats. Method: The liposomes were prepared by entrapping dexketoprofen in vesicular systems stabilized with chitosan. The in vivo biocompatibility was evaluated after oral administration in white Wistar rats: Group I (DW): distilled water 0.3 mL/100 g body weight; Group II (DEX): dexketoprofen 10 mg/kg body weight (kbw); Group III (nano-DEX): liposomes containing dexketoprofen 10 mg/kbw. Blood samples were collected from caudal lateral vein one day and seven days after the substance administration, to assess the eventual hematological, biochemical, and immunological changes. The investigation of somatic pain reactivity was performed using the hot plate test, to count the latency time response evoked by the thermal paws’ noxious stimulation. Results: Original liposomes entrapping dexketoprofen, with mean size of 680 nm and good stability, were designed. Laboratory analysis indicated no substantial variances between the three treated groups. The treatment with liposomes containing dexketoprofen resulted in a prolongation of the latency time response, statistically significant in the interval between 90 min and 10 h, in the hot plate test. Conclusions: The use of liposomes with dexketoprofen proved a good in vivo biocompatibility in rats and prolonged analgesic effects in the hot plate test.

Download Full-text